|
Molecular characterization and in vitro antifungal susceptibilities of 75 clinical Zygomycetes isolated in Delhi, India (click for details) |
|
|
|
In vitro activity of 8 antifungal drugs against 126 environmental and clinical isolates of Aureobasidium pullulans (click for details) |
|
|
|
Molecular identification of Veronaea botryosa by use of amplified fragment length polymorphism, including in vitro antifungal susceptibility profile (click for details) |
|
|
|
In vitro activities of nine antifungal drugs against 81 isolates of cutaneous fungi in Phialophora and Cyphellophora (click for details) |
|
|
|
Chromoblastomycosis by Fonsecaea: Infection routes, detection and therapy (click for details) |
|
|
|
Schizophyllum commune as an emerging fungal pathogen in India (click for details) |
|
|
|
In vitro antifungal susceptibility of eight drugs against Exophiala dermatitidis, a systemic opportunist (click for details) |
|
|
|
First case of subcutaneous Phaeohyphomycosis caused by Exophiala equina in South Korea and its susceptibility to eight antifungal drugs (click for details) |
|
|
|
In vitro antifungal activity of Isavuconazole to Madurella mycetomatis, the causative agent of black-grain mycetoma (click for details) |
|
|
|
Evaluation of genetic diversity by use of DNA sequencing and PCR-AFLP with antifungal susceptibility profile for Horteaea wernekii (click for details) |
|
|
